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Abstract: Formulation of multifunctional biopolymer-based scaffolds is one of the major focuses in 
modern tissue engineering and regenerative medicine. Besides proper mechanical/chemical 
properties, an ideal scaffold should: (i) possess a well-tuned porous internal structure for cell 
seeding/growth and (ii) host bioactive molecules to be protected against biodegradation and 
presented to cells when required. Alginate hydrogels were extensively developed to serve as 
scaffolds, and recent advances in the hydrogel formulation demonstrate their applicability as 
“ideal” soft scaffolds. This review focuses on advanced porous alginate scaffolds (PAS) fabricated 
using hard templating on vaterite CaCO3 crystals. These novel tailor-made soft structures can be 
prepared at physiologically relevant conditions offering a high level of control over their internal 
structure and high performance for loading/release of bioactive macromolecules. The novel 
approach to assemble PAS is compared with traditional methods used for fabrication of porous 
alginate hydrogels. Finally, future perspectives and applications of PAS for advanced cell culture, 
tissue engineering, and drug testing are discussed. 
Keywords: calcium alginate; porous hydrogel; polymer scaffold; calcium carbonate; encapsulation; 
drug delivery; cell culture 
 
1. Introduction 
At present, in the field of biomedical technologies, researchers have been attracted to the 
development of novel multifunctional structures with structure and properties well-controlled on 
both the micro- and nano-scales. One of the major focuses in tissue engineering and regenerative 
medicine is the formation of polymer scaffolds, temporal or permanent constructions providing both 
mechanical support for cell seeding and growth, as well as encapsulation/protection and controlled 
delivery of bioactive molecules (for instance, growth factors and enzymes) in order to guide tissue 
organization. Besides the tissue engineering for regenerative medicine, such scaffolds can serve as a 
platform for animal-free drug testing. Up to date, fabrication of multifunctional scaffolds that have a 
well-defined structure remains challengeable due to a high level of complexity in the composition of 
such scaffolds and the need to employ sophisticated methods for the scaffold assembly. In addition, 
conditions of scaffold preparation often require intolerably high costs of exclusive techniques and 
often result in a loss of bioactivity of bioactives loaded into scaffolds. Thus arises the need to develop 
simple strategies for the manufacture of intelligent polymer-based scaffolds possessing a 
well-controlled internal structure, efficient encapsulation, protection, and controlled release of 
desired bioactives (recent reviews [1–4]). 
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Polymeric 3D scaffolds serve as the supports to guide the growth of biological cells and the 
development of a microtissue; often these scaffolds are biodegradable. Polymeric scaffolds are 
usually designed as porous structures with highly developed internal surfaces to ensure cell 
infiltration/growth and to avoid diffusion limitations for transport of nutrition and metabolites. This 
also mimics the architecture of natural tissues well (Figure 1). 
 
Figure 1. SEM/cryo-SEM images of mammalian tissues (a–d) and porous polymer-based 
scaffolds that mimic corresponding tissues (e–h): (a,e) human trabecular bone. 
Reproduced with permission from [5], published by Springer Nature, 2011 and [6], 
published by Elsevier B.V., 2012; (b,f) human uterine peripheral vessels. Reproduced with 
permission from [7], published by Via Medica, 2004 and [8], published by Elsevier B.V., 
2005; (c,g) porcine muscular tissue. Reproduced with permission from [9], published by 
Springer Nature, 2018; (d,h) human transverse cervical nerves. Reproduced with 
permission from [10], published by Springer-Verlag, 1977 and [11], published by Springer 
Nature, 2019 
Among the others, alginate hydrogels are one of the pivotal materials used for the fabrication of 
polymeric scaffolds due to alginate biocompatibility, opportunity to shape alginate hydrogels into a 
variety of sophisticated geometries and topologies. This is possible in both 2D (e.g., thin films 
patterned with microwells [12] and gel grids [13]) and in 3D (sponge-like structures [14] and gels 
possessing tube-like [15] or spherical pores [16,17]). 
In recent years, a novel bench-top method has been proposed for the fabrication of porous 
alginate scaffolds (PAS) [18,19]. These scaffolds are produced by formulation of alginate mixture 
with vaterite calcium carbonate microcrystals (cores), followed by elimination of the CaCO3 cores 
under mild conditions including physiological pH. This is accompanied by the release of Ca2+ ions 
inducing the cross-linking of the alginate gel and formation of hollow pores as inverse replica of the 
cores. Schematic representation of the process of PAS formation using calcium carbonate is given 
and discussed in details in Section 4.1 of this review. PAS have highly developed internal structure 
and offer unique opportunities to host bioactive molecules of a different nature via proper 
localization of them in the scaffold and to release these molecules in a controlled manner [18,19]. 
This review summarizes different aspects of the PAS formation discussing current 
achievements and challenges in this field. Critical comparison of PAS with other approaches 
proposed to tackle the problems associated with the design of multifunctional scaffolds allows for 
manifesting high potential of the novel developed technology for tissue engineering, regenerative 
medicine, drug testing and other applications where multifunctional polymer-based scaffolds are 
currently employed and strongly required. 
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2. Ca2+-Alginate Gel Based Scaffolds 
2.1. Chemistry of Alginate 
Alginic acid is a naturally-derived block copolymer forming polyanions which macromolecule 
is composed of α-L-glucoronate and β-D-mannuronate units (Figure 2a) [20–25]. Sequence, and 
hence the properties of alginic acid, depend on the natural source. Commercially available alginic 
acid is produced from brown algae and usually available as in the form of the salt called alginate; 
molecular weights of these alginates typically vary from 32 to 400 kDa [22]. Since dissociation 
constants (pKa) of carboxylic groups of alginate are 3.65 and 3.38 for α-L-glucoronate and 
β-D-mannuronate residues, respectively, [21,26] in order to dissolve alginate, it is essential to 
achieve pH above a certain critical value, higher than the pKa. Besides this, viscosity of alginate 
depends on the ionic strength and, remarkably, the addition of some ions causes alginate gelation. 
The latest provides great advantages to alginate compared with the other polysaccharides (gelatine, 
agar) because alginate is able to form a gel in the range 0−100 °C. Moreover, alginate gels are highly 
hydrated, having water content > 95%, and can be heated without melting (phase transition) [24]. 
Chemical modification of alginate is widely employed to provide the polymer with novel 
desired properties (solubility, hydrophobicity, affinity to specific molecules, etc.) [20,22]. Thus, the 
phosphorylation of alginate results in the enhancement of hydroxyapatite nucleation and growth. 
Alginate sulfonation has been applied to provoke anticoagulant activity of the alginate. The attempts 
to transform hydrophilic alginate to a molecule with hydrophobic or amphiphilic properties were 
also demonstrated. The other way to provide alginate with new properties is based on the graft 
copolymerization. Alginates can also be functionalized with specific cell-targeting ligands in order 
to strengthen the affinity of alginate gels to biological cells. In the next section, the gelation and 
properties of alginate hydrogels will be discussed. 
 
Figure 2. (a) Chemical structure of α-L-guluronic and β-D-mannuronic acids (residues of 
alginate macromolecules). (b) Schematics of the binding between G-blocks of alginate 
molecules by means of divalent metal ions (M2+). 
2.2. Alginate Hydrogels: Formation and Structure 
Alginate hydrogels are highly hydrated 3D cross-linked polymer networks [20,22,24]. In 
general, alginate molecules chelate with multivalent cations. This process leads to the gelation 
occurring via the precipitation of alginate-cation complex and hence the formation of ionically 
cross-linked gels, also widely called physical gels. The chemistry behind this process is based on the 
cooperative binding between glucoronates (G-blocks), between mannuronates (M-blocks) and 
between glucoronates with mannuronates (MG-blocks). Of note, the binding between G-blocks is the 
most pronounced, although all types of the binding strongly depend on the type of the gel-forming 
cation. For instance, divalent ions Ca2+, Ba2+, and Sr2+ bound mainly to GG−dimers, while trivalent 
lanthanide ions such as La3+, Pr3+, and Nd3+ prone to bind to both GG− and MM−segments. This 
molecular organisation results in the formation of a diamond-shaped hole consisting of a 
hydrophilic cavity with the multivalent cation that coordinates oxygen atoms from the carboxyl 
groups of alginate (Figure 2b) [20–22,25,27,28]. The size of the cooperative unit is estimated to consist 
of more than 20 monomers [25]. It has been demonstrated that alginate affinity to cations increases in 
the order of Mn < Zn, Ni, Co < Fe < Ca < Sr < Ba < Cd < Cu < Pb [24,29]. This is directly related to the 
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ionic radius and coordination number of cross-linking cations [23] and can be used to tune the 
properties of the hydrogel. Among others, Ca2+ cross-linked alginate gels have an advantage of a 
high biocompatibility, while the use of other cations may be limited due to the toxicity issue. Ca2+ 
cross-linked alginates gels are predominantly formed via the binding of glucuronic segments. 
Because of this, the strength of alginate gel is significantly influenced by the content of G-blocks. In 
general, the higher the gel strength, the lower its elasticity [21]. Hydrogels fabricated from alginate 
enriched with G-blocks form stiff and brittle gels, while high M content results in the formation of 
rather soft elastic gels [24]. 
External and internal gelation, as well as gelation upon cooling, represent three main 
techniques used to formulate ionic alginate gels [20,22,24]. External gelation which is also called a 
“diffusion method” is based on direct exposure of alginate into a solution containing cross-linking 
ions (e.g., CaCl2). Ca2+ ions diffuse from the continuous phase into alginate droplets cross-linking 
them and forming gel particles [21]. The main disadvantage of this method is the formation of 
non-uniform alginate hydrogels due to the establishment of a gradient of Ca2+ concentration towards 
the boundary of the hydrogel where it is in contact with the solution of Ca2+ and an extremely high 
rate of the cross-linking reaction [30–32]. To some extent, the problem of non-uniform distribution of 
the cations in external gelation method can be eliminated using alginates of higher molecular 
weights or carrying out gelation in the buffer solutions containing phosphate ions that also bind 
calcium ions and, in this way, compete with alginate. 
On the other hand, the internal gelation (so-called “in situ gelation”) can be applied to avoid the 
gel inhomogeneity. For this approach, the source of Ca2+ ions (usually particles of low-soluble CaCO3 
or other salts of Ca2+) is distributed within the precursor solution of alginate. Slow dissolution of 
these particles is generally induced by changing pH (e.g., by addition of self-hydrolysing polymer as 
D-glucono-δ-lactone, GDL), providing constant flow of crosslinking ions to surrounding alginate 
molecules. This method results in a uniform ion concentration throughout the gel. As an alternative 
method, gelation upon cooling [23] is based on consequent dissolution of alginate solution and 
calcium salt in a hot medium of 90 °C followed by cooling. At the temperature of 90 °C, high thermal 
energy of alginate chains prevents alignment of the polymers required for gelation (Figure 2b) and 
irreversibly obstructs cooperative binding of the monomers. Further cooling facilitates the formation 
of an ordered inter-polymer structure that results in the formation of a homogeneous gel matrix [29]. 
However, the elevated temperatures used in this approach are unsuitable when using labile and 
fragile bio-macromolecules (e.g., growth factors). 
Hydrogel properties are easily tunable via adjusting alginate composition and gel fabrication 
approach [33–38], as well as the type of crosslinking counterions, the ionic strength, the molecular 
weight of alginate (reflecting its viscosity), pH and the temperature [39–44]. 
Besides ionically cross-linked (physical) hydrogels, alginate can also form covalently 
cross-linked (chemical) hydrogels. In general, covalently cross-linked alginate gels have higher 
mechanical and chemical resistance compared to those of physical hydrogels [20]. Chemical 
hydrogels possess a high stability in a wide range of pH (between 1 and 13), temperature (from 0 up 
to 100 °C), and various polar solvents and high ionic strength as well [20]. On the other hand, 
physical hydrogels are reversible because they are formed due to conformational changes, whereas 
chemical hydrogels form a permanent structure that is irreversible because of configurational 
changes occurring during hydrogel formation. Largely, this reversibility of physical hydrogels 
makes them favourable candidates for a variety of biomedical applications. Other advantages of 
physical and chemical hydrogels are described elsewhere [45]. Further in this review, physical 
hydrogels will be considered if not mentioned otherwise. 
2.3. Alginate Gels as Drug Carriers: Encapsulation and Release 
The tailor-made structure and widely tuneable properties of alginate hydrogels, as well as their 
biocompatibility, make them favourable candidates for versatile biological and medical applications. 
Thus, alginate hydrogels have been extensively developed as nano- or micro-formulations (in a form 
of gel particles, beads, or capsules) for controlled drug delivery, as well as materials for wound care 
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and engineering of microtissues [20–24]. The opportunity to encapsulate bioactives into alginate 
hydrogels under mild conditions, as well as release them in a controlled manner, plays a crucial role 
for all of these applications and will further be considered more in detail.  
Alginate hydrogels are versatile matrices allowing to encapsulate living cells, macromolecules 
(proteins, growth factors, enzymes, etc.), therapeutic molecules or functional nanomaterials into the 
gel network preserving their bioactivity and functions [22,23,25,46–49]. First achieved almost four 
decades ago, the encapsulation of islet cells into alginate hydrogel gave rise to their use for cell 
culture and opened new avenues for tissue engineering [29]. Nearly at the same time, alginate 
particles have been proposed as containers for encapsulation of molecules [24]. To form alginate 
beads, at first the alginate solution is usually mixed with the solution of the molecules of interest or 
the suspension of cells. Then, two scenarios for the preparation of alginate beads are possible. The 
straightforward way is based on the further exposure of this mixture to the solution of cross-linking 
ions (employing one of the methods described above) that leads to the formation of the large piece of 
a hydrogel. Further, smaller alginate beads can be obtained via mechanical breakdown of a bulk gel 
into the particles of a desired size. However, this approach concedes the opposite way that is usually 
employed. Namely, the alginate solution mixed with an encapsulated component is immersed into 
the cross-linking solution drop by drop [21,24]. Depending on the droplet fabrication approach, 
formed alginate particles range from macro dimensions (> 1 mm) down to nano-beads (< 0.2 µm). 
Notably, encapsulated components can be either homogeneously distributed over the whole bead 
volume or concentrated into the centre of a gel bead (e.g., one cell per a single bead) [21,23,24,48–50]. 
Thus, alginate macro-beads (1−2 mm) can be fabricated using the extrusion method when alginate is 
dripped into the CaCl2 bath using a syringe. Modification of this method via employment of an 
electric field, mechanical vibration, or by using a rotating device results in the formation of 
microbeads (0.2−1000 µm). A variety of other methods for the fabrication of alginate micro-beads 
have also been reported and are described elsewhere [21,23,24,48–50]. Alginate nano-beads (200 nm 
and less) are typically produced employing nano-vesicles and emulsion droplets as sacrificial 
templates. This templating strategy allows for designing not only matrix-type but also hollow 
structures (nano-capsules) that are formed after elimination of the template. Herein, among others 
we would like to highlight the use of insoluble vaterite CaCO3 crystals as they will be a key for the 
formulation of PAS. The originality of the use of these crystals arises from its ability to 
simultaneously serve as sacrificial templates and a source of Ca2+.  
A high water content and porous nature of alginate gels (pore sizes in the range 5−200 nm) 
result in a relatively fast diffusion of biomolecules and drugs within the gel [21,22]. Indeed, the 
release kinetics directly depend on the gel porosity which can be well-tuned by varying the number 
of cross-linking cations and its type, composition (source and chemical modification, if applicable) of 
alginate and the size of alginate beads [21]. As a general rule, smaller pores of 12−16 nm are typical 
for alginate gels prepared using the diffusion method of gelation, while hydrogels prepared via in 
situ gelation have larger pores. 
Strong electrostatic interaction of alginate matrix with the charged encapsulates also affects the 
release kinetics. For instance, simultaneous encapsulation of multiple drugs (methotrexate, 
doxorubicin, and mitoxantrone) has been demonstrated in [51]. It was found that methotrexate that 
does not interact with alginate rapidly liberates from the hydrogel while covalently bound 
doxorubicin releases with lower rates via chemical hydrolysis of the cross-linker, and mitoxantrone 
that is ionically bound to alginate releases only after dissociation of the hydrogel. Mild conditions 
used during the encapsulation and the gelation minimize protein denaturation and degradation, 
making alginate an excellent candidate for loading of protein-based bioactives. This stimulated a 
number of studies aimed at loading/release of a wide range of proteins and nucleic acids [22,25]. 
It is important to note that mammalian cells have no enzymes to cleave alginate chains which 
make alginate hydrogels non-degradable in mammals. Therefore, molecular diffusion and erosion of 
the polymer network are the only two factors that determine the release kinetics of bioactives. While 
the first scenario of erosion-mediated release is typically observed for prolonged release, the second 
one (diffusion-mediated release) is usually rather fast and accompanied by a low loading efficiency. 
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The latest results in spontaneous leakage of bioactives from alginate beads. Deceleration of 
diffusion-mediated release has been reported to be achieved via additional protection of the 
hydrogel beads using the layer-by-layer (LbL) assembled polymer multilayer shell [21,22]. Due to 
their chemical structure, alginate gels shrink at a low pH and swell at a neutral pH. At a very high 
pH or in the presence of EDTA or citric acid as cation chelators the cross-linking ions are released 
that leads to the dissolution of the gel inducing erosion-mediated release. This phenomenon has 
been widely used for pH-induced release from alginate hydrogels [21]. 
2.4. Alginate Gels for the Design of Porous Scaffolds 
Traditionally, polymer scaffolds for tissue engineering are fabricated using naturally derived 
biomaterials. Among them, alginate hydrogels have been extensively developed due to their 
similarity to extracellular matrix of mammalian tissues in terms of mechanical properties and widely 
tunable kinetics of hydrogel degradation, as well as controlled release of molecules at various pH 
values including neutral pH [33,52,53]. A wide range of bio-applications of alginate hydrogels 
includes but not limits to cell transplantation, wound healing, encapsulation and controlled or 
programmed delivery of drugs and biomacromolecules, and the use as anti-adhesive and repair 
materials [22,23,32,46,54–57]. Recent progress in the development of alginate hydrogels for the 
fabrication of scaffolds showed the employment of a number of advanced techniques including gas 
foaming [58], 3D printing [59,60], electrospinning [60–62], emulsion freeze drying [63], microfluidics 
[58,64], etc. Alginate gels serve as platforms for cell culture and growth of microtissues [65], 
cardiovascular muscles [66], bones [67], liver [68,69], etc. 
Design of hydrogels on the macroscopic level assumes control over the size and porous 
structure of the gels [70]. Hydrogel matrices can be either non-porous (having only small pores that 
are typically in the range of tens of nm for the alginate gel network [71]) or contain macroscopic 
pores that are typically in the range of 10–500 µm [72] (Figure 3). Dual nano- and macro-porosity is 
essential for controlled growth of a tissue and drug delivery [70]. 
 
Figure 3. (a) Scheme of the architecture of porous and non-porous hydrogels. Reproduced 
with permission from [70], published by Springer Nature, 2016; (b,d) Photographs of wet 
alginate scaffolds and (c,e) SEM images of dry alginate scaffolds: (b,c) — non-porous. 
Reproduced with permission from [71], published by John Wiley & Sons, 2016; (d,e) — 
porous alginate scaffold. Reproduced with permission from [72], published by 
Springer-Verlag Berlin Heidelberg, 2018. 
High stability of ionically cross-linked alginate gels makes it possible to fabricate a gel with 
defined dimensions and geometries using different patterning techniques [12,55,73] including 
light-triggered pattering and employment of microfluidics [54,56,74], electrochemical methods [75], 
etc. However, utilization of lithography and 3D printing technologies are usually required for 
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design of any hydrogel. The use of harsh conditions during scaffold fabrication (e.g. high or low 
temperatures, exposure to gas-liquid or solid-liquid interface, the use of organic solvents and 
aggressive media, surfactants) still remains an obstacle. This often does not allow us to encapsulate 
bioactives during the hydrogel synthesis that may be crucial for utilization of scaffolds and limits the 
control over the scaffold internal structure [47]. 
The latest issue is typically accompanied by scarce pore interconnectivity that is essential for 
cell colonization in the entire volume of the scaffold. This problem has partially been solved by A. 
Barbetta et. al. [76]. Therein, two methodologies for the formulation of PAS with highly 
interconnected pores in different size ranges have been proposed. Emulsion templating of the 
hydrogel allowed producing PAS with the pores of about 10–20 µm that are interconnected via the 
channels of 2–5 µm [76]. An approach based on the foam templating results in the formation of 
alginate gels with large 100-300 µm pores and interconnections in the range of 30–80 µm [76]. Both 
methods allow one to produce PAS with a highly developed internal macro-sized structure that is 
crucial for cell growth and proliferation due to a need for a free space for cell colonization and 
requirements of a non-restricted transport of cell metabolites and essential nutrients. However, both 
approaches [76] lack precise control over the pore distribution that appears random and does not 
give any options for loading of therapeutics and growth factors, important for cell attachment, 
growth and proliferation. 
This seems to be one of the major challenges for further progress in this field. To the best of our 
knowledge, only a few works reported the formation of alginate hydrogels with an opportunity to 
host macromolecules, and no alginate gels possessing both a well-defined internal structure and 
loading of bioactives at desired doses have been reported. In this sense, one of the most promising 
methodologies is the templating of alginate hydrogels on mesoporous vaterite CaCO3 crystals (the 
strategy that has been briefly mentioned above). Explored by Wang et al. [16] and by Roberts and 
co-workers [17], this idea has been implemented employing model molecules (ibuprofen [16] and 
bovine serum albumin (BSA) [17]) that have been pre-loaded to CaCO3 vaterite crystals. A 
suspension of these crystals has been mixed with the solution of alginate followed by addition of 
glucono-δ-lactone that slowly doped H+ due to its hydrolysis. The acidification caused a mild 
dissolution of CaCO3 and release of Ca2+ that cross-link the alginate forming a gel. Macro-sized pores 
have been formed as a result of calcium carbonate dissolution in the places where CaCO3 crystals 
have been initially located. Consequently, ibuprofen [16] and BSA [17] have been rapidly liberated 
from the PAS. Additional coating of CaCO3 with a polyelectrolyte multilayer shell resulted in 
slowing down the release rate by ca 50 times as compared with alginate gels formed using bare 
CaCO3 crystals [17]. These works manifested that the utilization of CaCO3 crystals as soluble cores 
for templating alginate hydrogels is a powerful approach promising for the development of 
scaffolds towards cell-based applications. However, the approach above is rather sophisticated and 
involves multiple steps including a rather long procedure of multilayer coating bringing additional 
costs. The way proposed to avoid these issues and novel achievements in CaCO3-assistant formation 
of PAS will be addressed in the section 4 of this review. However, prior to this, the following section 
3 will describe the structure, principles of the fabrication, and featured properties of vaterite CaCO3 
crystals. 
3. CaCO3 Vaterite Crystals: Loading and Release Opportunities 
3.1. Morphology of Vaterite Caco3 Crystals 
Calcium carbonate mainly exists in the form of one of three polymorphs: calcite, vaterite and 
aragonite (Figure 4a–c). All the polymorphs have different shapes and morphologies that can be 
distinguished from each other employing various methods, for instance X-ray diffraction (Figure 4d) 
or Raman spectroscopy (Figure 4e). Among all of the polymorphs, vaterite is the most attractive for 
biomedical applications because it has a highly developed internal structure ideal for 
microencapsulation/release of bio-macromolecules and drugs. Vaterite CaCO3 crystals can easily be 
formed upon mixing of aqueous solutions of precursor salts of Ca2+ and carbonate ions. The 
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mechanism of crystal growth is expletively described elsewhere [77,78]. Briefly, spherical vaterite 
crystals comprise of small nanocrystallines interconnected to each other forming mesoporous 
structure of the crystal. The use of organic additives [79], some protein/polymer matrices [80] or 
nanoparticles [81] can direct the growth of vaterite crystals of specific shape and morphology. The 
porosity of the crystals can also be controlled, e.g. via the variation of crystal preparation 
temperature [82]. The typical sizes of crystals range from 3 to 20 µm, although a number of recent 
studies proposed novel ways for the fabrication of nano-crystals [79,80,83] or large vaterite of sizes 
in sub-millimeter range [84]. 
 
Figure 4. Scanning electron microscopy (SEM) images of CaCO3 polymorphs: (a) 
rhombohedral calcilte, (b) needle aragonite and (c) spherical vaterite. Reproduced with 
permission from [85], published by Elsevier, 2016. (d) XRD and (e) Raman spectra of the 
synthetically prepared calcite (A), aragonite (B) and vaterite (C). Reproduced with 
permission from [86], published by Royal Society of Chemistry (Great Britain), 2000. 
3.2. Vaterite CaCO3 as Decomposable Templates for Microencapsulation 
Nowadays, inorganic crystals of the vaterite polymorph of CaCO3 are classified as advanced 
biodegradable and biocompatible materials to be employed for a wide range of bio-applications 
such as biomedical engineering, biosensors and controlled drug delivery. The growing interest in 
vaterite CaCO3 has emerged based on crystal highly porous nature, easy adjustment of dimensions 
and porosity during the crystal synthesis, cost-effective formulation and marginal toxicity [87–91]. 
Indeed, the internal structure of vaterite crystals is mesoporous with the typical pore size of tens of 
nanometers that is highly favorable for the loading of bio-macromolecules and drugs as well as 
functional materials such as inorganic nanoparticles (e.g., magnetite [92–95], silver [95,96]), carbon 
nanotubes and halloysites [97]. CaCO3 crystals can be loaded with the low-molecular-weight 
molecules, e.g., small drugs (doxorubicin [98]) and photosensitizer [99], as well as with 
high-molecular-weight macromolecules, e.g., dextrans [88,90], polymers (alginate [90], mucin 
[100,101]), and proteins (catalase, BSA, insulin [88–90,102,103]). The functionalization of CaCO3 
vaterite crystals with inorganic nanoparticles brings new properties desired for the use of crystals in 
surface enhanced Raman microscopy [96,104–106], making crystals sensitive to external stimuli (e.g., 
electrical/magnetic fields, light irradiation [107–110]). The fabrication of pure protein [102,111,112] or 
polymer [113–115] particles can be achieved via hard templating on the vaterite cores. The 
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templating is based on filling the crystal pores with material of interest followed by the crystal 
elimination that results in the formation of the inverted crystal replica (in case of a full filling of the 
pores). This opens new avenues for the utilization of vaterite CaCO3 crystals and hybrid structures 
assembled on them as sacrificial templates [116], for controlled release, targeted drug delivery [83], 
surface patterning [117], and reconstitution of artificial cellular compartments [118]. 
Impregnation of the encapsulates into the interior of the vaterite CaCO3 crystals can be 
performed at mild conditions in one of two ways: i) during the crystal growth (so-called 
co-precipitation or co-synthesis) or via the post-loading of the pores of pre-formed crystals (by 
means of adsorption or via solvent evaporation) [81,89,90,102,119,120]. All methods for the 
encapsulation have their advantages and disadvantages; the choice of appropriate approach mainly 
depends on the nature of the encapsulate. Thus, post-loading by means of adsorption represents the 
mildest method suitable for the encapsulation of fragile macromolecules that are highly sensitive to 
their microenvironment and can easily lose their bio-activity [120,121]. In its turn, the 
co-precipitation approach is based on the inclusion of encapsulates into one of the precursor salt 
solutions to make the crystals, further mixing of the salts and entrapment of encapsulates inside the 
growing crystals. This leads to higher encapsulation efficiencies if compared to the adsorption 
method, but may result in a partial loss of the bio-activity of the encapsulated molecules caused by 
the influence of crystal growth conditions [121]. On the other hand, the co-precipitation provides a 
homogeneous distribution of molecules within an interconnected internal volume of vaterite 
crystals. Finally, solvent evaporation grants the highest encapsulation efficiencies, yet it is however 
the harshest method among three approaches described above due to conditions of solvent removal 
and it is thus less suitable for labile [121] and sensitive molecules [83]. 
Besides the integration of molecules of interest inside the crystals, deposition of additional 
coatings onto the external surface of the crystals can also be achieved, e.g. via the LbL assembly of 
the polyelectrolytes [88,98,109,122–124]. Importantly, the multilayer shells assembled on the crystals 
are fully permeable for ions and small molecules that allows for a complete decomposition of CaCO3 
cores when lowering pH or using chelating agents (e.g., EDTA). This results in the formation of 
completely hollow polyelectrolyte capsules or capsules of a matrix type that contain a polymer 
matrix inside [125]. The most attractive feature of multilayer capsules assembled on CaCO3 cores is a 
selective permeability of a multilayer shell that can also be functionalized with some 
stimuli-sensitive materials (e.g., those responsive to pH [126], infra-red light [127,128]), so the 
encapsulated molecules can be released from the capsule in a controlled manner [129]. 
3.3. Release from Vaterite Caco3 Crystal: Dissolution and Recrystallization 
If not considering the case of molecular release from functionalized vaterite CaCO3 crystals that 
is mediated by external stimuli, one can distinguish two main mechanisms of the release from bare 
CaCO3 crystals: dissolution- and recrystallization -mediated release. CaCO3 can easily be dissolved 
at a slightly acidic pH [116] or upon the addition of chelating agents, e.g., EDTA or citric acid 
(corresponding constants of the binding to Ca2+ in the CaCl2 solution are Ka ~ 2 × 108 M−1, and Ka ~ 103.5 
M−1 at pH 7 for EDTA and citric acid, respectively). While acidic pH is not desirable for sensitive 
compounds such as proteins or growth factors, dissolution of CaCO3 crystals at neutral pH has a 
crucial importance for bio-applications providing a complete release of the loaded molecules.  
On the other hand, the immersion of mesoporous vaterite crystals into aqueous media results in 
a phase transition and spontaneous recrystallization of vaterite to thermodynamically more stable 
but non-porous calcite. If the crystals have been laden with some molecules of interest, the 
transformation of the vaterite to calcite provokes the liberation of these molecules from the porous 
interior of vaterite crystals to external medium [130,131]. 
It is known that vaterite → calcite recrystallization is to a large extent a surface-mediated 
process [78,132–134] and recrystallization kinetics usually exhibits an exponential-like behavior [81]. 
The recrystallization kinetics can be controlled via the use of additives. For instance, CaCO3-Fe3O4 
vaterite microparticles recrystallize significantly faster if compared with pure vaterite crystals [81]. 
The LbL assembled polyelectrolyte coating of pre-loaded CaCO3 crystals can also effectively regulate 
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molecular and ion transport on the crystal-liquid interface allowing us to program the release 
kinetics [81]. 
As a short summary of the described above, unique properties of vaterite crystals are in their i) 
biocompatibility, ii) ability to trap and retain huge amounts of small and large molecules and 
nanoparticles of various nature, (iii) opportunity to encapsulate bioactives at mild conditions and 
neutral pH; and iv) wide range of options for programmed and controlled slow/fast release that is 
either regulated via crystal dissolution and recrystallization (for the bare crystals) or by external 
stimuli (for functionalized crystals). In recent years, these features stimulated the idea to utilize 
vaterite calcium carbonate as sacrificial templates for the fabrication of polymer-based alginate 
scaffolds. In principle, this strategy can provide simultaneous i) cross-linking and adjustment of 
hydrogel nanoporosity; ii) control over the macroporosity of porous scaffolds and iii) encapsulation 
and preservation of fragile bioactives in the entire volume of the scaffold. This makes the use of 
mesoporous CaCO3 crystals for the fabrication of PAS a beneficial and superior approach. Latest 
achievements in this area are discussed below in Section 4. 
4. Vaterite CaCO3-Assistant Porous Alginate Scaffolds (PAS) 
4.1. Fabrication Strategy 
In a majority of works focused on composite CaCO3-alginate gel materials, CaCO3 crystals are 
used as a source for mineralization [135] of the scaffolds and/or as a hardening component for the 
scaffolds utilized in hard tissue engineering (e.g., [136,137]). Therefore, there was no need to 
eliminate CaCO3 crystals in order to form the pores, and even vice versa, the crystals have been kept 
in the final scaffold architecture. A straightforward approach for the fabrication of composite 
CaCO3-alginate gel materials was first employed nearly one decade ago and has been based on the 
simultaneous growth of CaCO3 crystals and gelation of alginate hydrogel [138–142]. In this design, 
calcium carbonate crystals grow in the presence of the gel and get entrapped inside this polymer 
matrix. This strategy showed its promise for the controlled crystallization of CaCO3 crystals. 
However, it has serious limitations. The major one is a lack of control over the internal structure of 
the scaffold. Although the structure of the growing crystals can be manipulated via the variation of 
environmental conditions (polymer concentration, gel composition, etc.), the final distribution of 
crystals and the macrostructure of the scaffold cannot be controlled since the crystallization of 
CaCO3 is a spontaneous and highly sensitive process. In addition, the presence of calcite and 
sometimes amorphous calcium carbonate has been detected [139]. For some cases, a significant 
decrease in the size of CaCO3 crystals resulted in the formation of nano-CaCO3 that found its 
application in drug delivery but was not suitable for the fabrication of macro-porous scaffolds [141]. 
In contrast, the utilization of vaterite CaCO3 crystals as sacrificial cores for the formation of 
alginate scaffolds in microfluidics set-up allows one to design stable PAS that have a well-defined 
and highly developed porous structure. The high potential of this fabrication strategy was recently 
manifested for the precise control over the scaffold porosity [18,19] and a high performance of the 
encapsulation/controlled release of biomolecules [19]. The work [18] introduced the method offering 
the fabrication of 2D CaCO3-assistant alginate scaffolds at acidic conditions (Figure 5a). Therein, 
CaCO3 crystals suspended in the alginate solution have been spread over a glass substrate (Figure 
5ai) followed by the addition of HCl that resulted in the dissolution of calcium carbonate and the 
release of Ca2+ ions that induces physical cross-linking of the hydrogel (Figure 5aii–iii). Control over 
the concentration of Ca2+ and as a result over the cross-linking degree has been achieved via 
variation of the ionic strength (Figure 5aiii). 
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Figure 5. (a) Schematics of formation of porous alginate hydrogels. (i,ii) Dispersion of 
CaCO3 crystals in alginate solution followed by deposition of the suspension onto a glass 
substrate. (ii,iii) Formation of porous hydrogel by addition of HCl, which induces CaCO3 
dissolution. The dissolution process is accompanied by alginate cross-linking and 
formation of hollow pores. (b) Optical transmission and fluorescent images of 33 µm 
vaterite CaCO3 crystals dispersed in alginate before (i,ii) and after (iii,iv) addition of HCl. 
Fluorescence profiles are given to each image and taken along the white interrupted lines. 
(c) CSLM images of porous alginate gel formed at compact packing of 11 µm CaCO3 
templates. White arrows in (c,ii) indicate interconnected pores. The gel (b,c) has been 
stained with rhodamine 6G. Reproduced with permission from [18], published by John 
Wiley & Sons, 2015. 
4.2. PAS Porosity and Mechanical Properties 
Gel cross-linking and osmotic pressure generated by the released calcium ions have been 
shown to play a pivotal role in the formation of the micro-sized pores in PAS [18]. Notably, the pores 
of the formed PAS are hollow (Figure 5b). The pH used for dissolution of the crystal core is the key 
to manipulate the stability and size of the pores during CaCO3 elimination. Thus, a less acidic pH 
(that can be achieved by addition of relatively low HCl concentration) results in the slow dissolution 
of CaCO3 that is accompanied by the collapse and closing of the pores. The use of high HCl 
concentration provokes fast dissolution of vaterite cores that results in the uncontrolled spontaneous 
formation of CO2 bubbles and the enlargement of the formed micro-sized pores. Under optimal 
acidic conditions, pores keep the size equal to that of the CaCO3 crystals used (Figure 5b). This 
allows a rather easy control over the pore size distribution via the utilization of vaterite crystals of 
desired dimensions [18]. 
The structure of the CaCO3-assistant PAS assembled on CaCO3 crystals of about 11 µm shown 
in Figure 5c clearly reveals the presence of both closed and interconnected pores. These scaffolds are 
soft, having the Young modulus of tens of kPa. A highly developed and tunable internal structure 
and soft nature of CaCO3-assistant PAS make them promising for the use in biomedical applications, 
e.g., for bio-engineering of soft tissues and organs (Figure 6). Another advantage is the opportunity 
to load and release bioactive molecules into the PAS. Therefore, the last section of this review will 
highlight recent achievements in the loading/release of non-charged dextrans, charged 
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bio-macromolecules (proteins) and small molecules (dyes) into/out of PAS assembled using vaterite 
CaCO3 crystals. 
4.3. PAS as Reservoirs for Encapsulation and Controlled Release 
Fluorescein isothiocyanate-labeled dextrans (FITC-dextran) are known as model 
macromolecules widely employed for investigation of the release performance and kinetics of 
various carriers. Dextrans have slightly negative zeta-potentials closed to zero at neutral pH and can 
have molecular weight variable in a wide range [143]. The kinetics of the release of dextrans from 
vaterite CaCO3 crystals has been extensively studied in recent years. The study [19] investigated the 
release of dextrans of different molecular weights from PASs assembled on ca 8 µm-sized CaCO3 
cores (Figure 7a). The release rate of FITC-dextran has been demonstrated to be directly related to its 
molecular weight that is rather typical for homogeneous matrices and indicates a significant role of 
spontaneous molecular diffusion. Interestingly, alginate concentration had no influence on 
FITC-dextran release [19]. Assuming the absence of strong electrostatic interaction between dextrans 
and PAS, it has been concluded that there is a cut off for the molecules of 7–16 nm, so larger 
macromolecules are retarded by the alginate network and small molecules can freely diffuse the gel 
outward. 
 
Figure 6. Comparison of Young’s modulus of natural soft tissues and organs and Young’s 
modulus of CaCO3-assisted PASs. Adopted with the permission from [144]. Reproduced 
with permission from [144], published by MDPI, Basel, 2015. 
 
Figure 7. (a) Release kinetics of FITC-dextran (different MW) release from the macro-pores 
of PAS. (b) Mass transport of proteins from the solution into/through the PAS gel network. 
Reproduced with permission from [19], published by American Chemical Society, 2015. 
Strong interaction between charged macromolecules (proteins) and alginate gel has also been 
reported. As opposed to the study of dextran release kinetics, the protein-PAS interaction has been 
examined assessing the loading of proteins into prepared PAS. Alginate gel itself possesses a 
negative charge due to a low pKa of the alginic acid. Small protein lysozyme (oppositely charged 
compared to alginate gel) accumulates inside PAS (Figure 7b) while negatively charged insulin 
reaches much lower internal concentration inside the PAS although its diffusion is also rather fast (a 
scale of minutes) [19]. This clearly indicates a high potential for the encapsulation of macromolecules 
Micromachines 2019, 10, 357 13 of 21 
 
that possess a positive net charge into the negatively charged PAS. At the same time, the retention of 
macromolecules processing a negative net charge can be awkward. The scenario described above 
can, however, be different in some special cases as it has been shown, for instance, for small anionic 
dye [145]. 
Therein, the dissolution of phthalocyanine-loaded CaCO3 crystals covered by an alginate matrix 
and re-distribution/release of CuPcTs dye molecules [146] has been monitored by Raman 
spectroscopy [145]. Notably, small CuPcTs molecules pre-encapsulated into sacrificial CaCO3 cores 
can be retained inside the macro-sized pores formed at the places of eliminated CaCO3 crystals that 
are probably due to the repulsion between negatively charged dye molecules and similarly charged 
ALG gel surrounding the pores. From the other side, the reason could be the aggregation of small 
dye molecules inside the pores of CaCO3 during the co-synthesis, so such large molecular 
aggregates cannot escape from the pores due to sterical limitations. In any case, these results are 
promising for the loading and retention of small and/or for anionic molecules inside the pores of 
the PAS. 
5. Summary and Perspectives 
Fabrication of porous biopolymer-based scaffolds is rapidly developing field of biomedical 
engineering. In this field, porous alginate scaffolds built up employing mesoporous vaterite CaCO3 
microcrystals are extremely promising due to i) highly porous PAS structure that can be well-tuned 
and ii) the ability to load the scaffolds with bioactive molecules of a diverse nature and release them 
on demand. Microfluidics-based design of CaCO3-assisted PASs utilizing pre-formed CaCO3 crystals 
offers a high degree of control over the internal PAS structure. As opposed to that, the simultaneous 
crystal growth and alginate gelation lacks the control over the PAS structure and does not provide 
an opportunity to pre-load CaCO3 cores with the desired active compounds. 
Despite the high potential of CaCO3-assisted PASs, their fabrication and use have not been 
investigated well yet, and it is better to say that nowadays this approach is only just emerging. 
Therefore, the design of CaCO3-assisted PASs requires a further deep development in terms of 
fundamental issues raised and applications. Thus, the fabrication of the scaffolds under mild 
conditions (media with the pH near the physiological one, i.e., pH 7.4) is urgently required as 
currently employed HCl-mediated leaching of CaCO3 cores may result in the reduction bioactives’ 
activity and cell viability. Thus, the investigation of the interaction of CaCO3-assisted PASs with cells 
will be a crucial step for further development of PASs. There is an intuitive perception that one of the 
best options would be the substitution of HCl as a relatively aggressive dissolution agent to weaker 
acids (e.g., citric acid) or chelating Ca2+-binding agents (e.g., EDTA). In principle, the latest can be 
achieved at neutral pH [114]. 
On the other hand, the strategies used to encapsulate bioactive compounds into CaCO3 cores 
and to protect the scaffolds from undesired spontaneous leakage of these bioactives should further 
be addressed, verified and improved. Herein, the entrapment of small and/or anionic compounds 
can turn up the challenge due to the relatively large nano-pores of alginate matrix of the PAS (7–16 
nm) and the negative charge of the alginate gel due to carboxylic groups on the alginate backbone. 
Here, one of the strategies might be the co-loading of these small drugs with large oppositely 
charged biopolymers. The formation of drug-biopolymer complexes inside the pores of CaCO3 
promotes the entrapment of the drugs and allows one to substantially increase encapsulation 
efficiency (e.g., [147,148]). Formation of LbL capsules on CaCO3 cores could be alternative strategy. 
Pioneering studies on the design of CaCO3-assisted PASs indicate that all obstacles mentioned 
above can potentially be overcome. We believe that the described PASs can become a new 
generation of biopolymer scaffolds with tailor-made architecture and controlled porosity, high pore 
interconnection and an opportunity to load and release biomolecules of interest. This allows one to 
use the terms intelligent or smart for the PASs, and opens a new avenue for further successful PAS 
employment towards tissue engineering and regenerative medicine. 
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